Baird analyst Jack Allen reiterated an Outperform rating and $18.00 price target on Voyager Therapeutics (NASDAQ: VYGR)The analyst comments 'In-person ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE